EYPT
Price
$13.69
Change
-$0.57 (-4.00%)
Updated
Dec 2, 04:23 PM (EDT)
Capitalization
1.18B
93 days until earnings call
Intraday BUY SELL Signals
LYRA
Price
$4.07
Change
+$0.34 (+9.12%)
Updated
Dec 2, 04:16 PM (EDT)
Capitalization
6.6M
Intraday BUY SELL Signals
Interact to see
Advertisement

EYPT vs LYRA

Header iconEYPT vs LYRA Comparison
Open Charts EYPT vs LYRABanner chart's image
EyePoint Pharmaceuticals
Price$13.69
Change-$0.57 (-4.00%)
Volume$900
Capitalization1.18B
Lyra Therapeutics
Price$4.07
Change+$0.34 (+9.12%)
Volume$100
Capitalization6.6M
EYPT vs LYRA Comparison Chart in %
EYPT
Daily Signal:
Gain/Loss:
LYRA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
EYPT vs. LYRA commentary
Dec 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EYPT is a Hold and LYRA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 02, 2025
Stock price -- (EYPT: $14.26 vs. LYRA: $3.72)
Brand notoriety: EYPT and LYRA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EYPT: 51% vs. LYRA: 45%
Market capitalization -- EYPT: $1.18B vs. LYRA: $6.6M
EYPT [@Biotechnology] is valued at $1.18B. LYRA’s [@Biotechnology] market capitalization is $6.6M. The market cap for tickers in the [@Biotechnology] industry ranges from $107.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EYPT’s FA Score shows that 1 FA rating(s) are green whileLYRA’s FA Score has 1 green FA rating(s).

  • EYPT’s FA Score: 1 green, 4 red.
  • LYRA’s FA Score: 1 green, 4 red.
According to our system of comparison, EYPT is a better buy in the long-term than LYRA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EYPT’s TA Score shows that 5 TA indicator(s) are bullish while LYRA’s TA Score has 5 bullish TA indicator(s).

  • EYPT’s TA Score: 5 bullish, 5 bearish.
  • LYRA’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, LYRA is a better buy in the short-term than EYPT.

Price Growth

EYPT (@Biotechnology) experienced а -0.97% price change this week, while LYRA (@Biotechnology) price change was +21.97% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.87%. For the same industry, the average monthly price growth was -3.86%, and the average quarterly price growth was +54.93%.

Reported Earning Dates

EYPT is expected to report earnings on Mar 05, 2026.

Industries' Descriptions

@Biotechnology (-0.87% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EYPT($1.18B) has a higher market cap than LYRA($6.6M). EYPT YTD gains are higher at: 91.409 vs. LYRA (-63.953). LYRA has higher annual earnings (EBITDA): -35.34M vs. EYPT (-172.05M). EYPT has more cash in the bank: 256M vs. LYRA (29.8M). EYPT has less debt than LYRA: EYPT (21.8M) vs LYRA (32.5M). EYPT has higher revenues than LYRA: EYPT (51.9M) vs LYRA (770K).
EYPTLYRAEYPT / LYRA
Capitalization1.18B6.6M17,886%
EBITDA-172.05M-35.34M487%
Gain YTD91.409-63.953-143%
P/E RatioN/AN/A-
Revenue51.9M770K6,740%
Total Cash256M29.8M859%
Total Debt21.8M32.5M67%
FUNDAMENTALS RATINGS
EYPT: Fundamental Ratings
EYPT
OUTLOOK RATING
1..100
25
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
PROFIT vs RISK RATING
1..100
71
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
13
SEASONALITY SCORE
1..100
65

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
EYPTLYRA
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
73%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
74%
Momentum
ODDS (%)
Bullish Trend 2 days ago
89%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 5 days ago
86%
Bullish Trend 2 days ago
79%
Declines
ODDS (%)
Bearish Trend 28 days ago
87%
Bearish Trend 8 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
84%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
EYPT
Daily Signal:
Gain/Loss:
LYRA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PEGZX21.60N/A
N/A
PGIM Jennison Mid-Cap Growth Z
JVASX40.56N/A
N/A
JPMorgan Value Advantage I
GESOX19.13-0.08
-0.42%
Lazard Global Equity Select Port Open
SMFYX42.71-0.39
-0.90%
American Beacon Stephens Mid-Cap Gr Y
GMSRX12.66-0.16
-1.25%
Nationwide Small Cap Index R

EYPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, EYPT has been loosely correlated with OCUL. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if EYPT jumps, then OCUL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EYPT
1D Price
Change %
EYPT100%
-3.84%
OCUL - EYPT
60%
Loosely correlated
-3.62%
LYRA - EYPT
58%
Loosely correlated
+0.81%
ATHE - EYPT
54%
Loosely correlated
-9.17%
IDYA - EYPT
50%
Loosely correlated
-3.71%
ERAS - EYPT
48%
Loosely correlated
-5.36%
More

LYRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, LYRA has been loosely correlated with EYPT. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if LYRA jumps, then EYPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LYRA
1D Price
Change %
LYRA100%
+0.81%
EYPT - LYRA
58%
Loosely correlated
-3.84%
VERA - LYRA
55%
Loosely correlated
-2.25%
KYMR - LYRA
51%
Loosely correlated
-1.50%
CLNN - LYRA
39%
Loosely correlated
-4.83%
TBPH - LYRA
35%
Loosely correlated
-3.42%
More